National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 18 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• Cause and Natural Course of Pediatric-Onset MastocytosisCompletedNCT00050193
• Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV DrugsCompletedNCT00050063
• Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host DiseaseCompletedNCT00048789Phase 2
• HIV Prevention Preparedness StudyCompletedNCT00048282
• Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant PatientsCompletedNCT00047983Early Phase 1
• HIV-1 Vaccine Test in Uninfected Adult VolunteersCompletedNCT00047931Phase 1
• Blood Factors in Mastocytosis and Unexplained Anaphylaxis and FlushingCompletedNCT00047918
• Rapid HIV Tests for Women Late in Pregnancy and During LaborTerminatedNCT00046436
• Phase I Trial of Smallpox VaccineCompletedNCT00046397Phase 1
• Multicenter AIDS Cohort Study (MACS)Status unknownNCT00046280
• Niacin for Treatment of Elevated Cholesterol and Triglycerides in HIV-Infected PatientsCompletedNCT00046267Not applicable
• Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug ResistanceCompletedNCT00046033Phase 2
• HIV-1 Vaccine Test in Uninfected Adult VolunteersWithdrawnNCT00045838Phase 1
• Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal WomenTerminatedNCT00044837Phase 1
• Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic SyndromeActive, not recruitingNCT00044304Phase 2
• HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)CompletedNCT00043641
• Safety of an HIV DNA Vaccine Given to HIV Uninfected AdultsCompletedNCT00043511Phase 1
• A Study of HIV Levels During Pregnancy and After ChildbirthCompletedNCT00041964
• Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease InhibitorCompletedNCT00041769Phase 3
• Daclizumab to Treat Wegener's GranulomatosisCompletedNCT00040248Phase 2
• Treatment of Multiple Sclerosis With Copaxone and AlbuterolCompletedNCT00039988Not applicable
• Interactions Between HIV Protease Inhibitors and Calcium Channel BlockersCompletedNCT00039975Phase 1
• Vaccinia Virus Vaccine (APSV) in Vaccinia- Naive Subjects: PILOTCompletedNCT00038987Phase 1/2
• A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk ContactsCompletedNCT00038688Phase 3
• Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected InfantsCompletedNCT00038480Phase 1
• A Study of DAPD Alone Versus DAPD Plus MMF for Treatment of HIV InfectionCompletedNCT00038272Phase 2
• Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug TherapyCompletedNCT00038259Not applicable
• Prevalence of Hepatitis C Virus Infection in HIV-Infected ChildrenCompletedNCT00037076
• A Study to See if Certain Antioxidants and Vitamins Will Keep Lactate Levels Down in Patients Taking Anti-HIV DrugsWithdrawnNCT00037063Not applicable
• Anti-CD20 in Systemic Lupus ErythematosusCompletedNCT00036491Phase 1/2
• Use of Muscle Spectroscopy to Evaluate Mitochondrial Dysfunction in HIV-Infected PatientsWithdrawnNCT00036478
• Effects of Changing HIV Therapy at Lower Versus Higher Viral LoadsCompletedNCT00036465Phase 2
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct ObservationCompletedNCT00036452Phase 2
• Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaTerminatedNCT00034528Phase 2
• Study of Anti-HIV Therapy IntensificationCompletedNCT00034086Not applicable
• Posaconazole to Treat Invasive Fungal InfectionsCompletedNCT00033982Phase 3
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIVCompletedNCT00033163Phase 2
• Dryvax Dilution-Prev Vacc AdultsCompletedNCT00032708Phase 2
• Pleconaril Enteroviral Sepsis SyndromeCompletedNCT00031512Phase 2
• Azithromycin/Bicillin SyphilisCompletedNCT00031499Phase 3
• Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant PatientsTerminatedNCT00031473Phase 3
• Valganciclovir in Congenital CMV InfantsCompletedNCT00031434Phase 1/2
• Neonatal CMV-Ganciclovir Follow-up StudyCompletedNCT00031421
• The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and RibavirinCompletedNCT00031343Phase 2
• Screening Protocol for HIV Vaccine StudiesCompletedNCT00031304
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in MonkeysCompletedNCT00031109Not applicable
• Increasing HAART-Induced Immune Restoration With CyclosporineCompletedNCT00031070Phase 2
• Vitamin B Therapy for HyperlactatemiaCompletedNCT00031057Not applicable
• Adding New Drugs for HIV Infected Patients Failing Current TherapyCompletedNCT00031044Phase 1/2
• Stem Cell Transplantation to Treat Leukocyte Adhesion DeficiencyCompletedNCT00031005Phase 2
• A Study to Prepare for Future HIV Vaccine StudiesCompletedNCT00029744
• A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the BodyCompletedNCT00029341Phase 2
• Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected PeopleCompletedNCT00028366Not applicable
• Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive CareCompletedNCT00028327Phase 3
• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsCompletedNCT00028314Not applicable
• Stem Cell Gene Therapy to Treat X-Linked Severe Combined Immunodeficiency (XSCID)CompletedNCT00028236Phase 1
• Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA GelCompletedNCT00028132Phase 1
• Immune Responses to HIV in Blood Cells in HIV-Infected and HIV-Uninfected VolunteersCompletedNCT00027482
• An Investigational Combination Vaccine Given to People Who Are Not Infected With HIVCompletedNCT00027365Phase 1
• A Comparison of Two Ways to Manage Anti-HIV Treatment (The SMART Study)CompletedNCT00027352
• Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIVCompletedNCT00027339Phase 2
• Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected AdultsCompletedNCT00027261Phase 1
• Use of a Test That Evaluates How the Body Handles Insulin and GlucoseCompletedNCT00027092
• A Study of Decreased Mental Function Associated With HIVCompletedNCT00027040Not applicable
• Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SCCompletedNCT00026624Phase 1
• A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated AdultsCompletedNCT00026611Phase 2
• Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral LoadCompletedNCT00025922
• Intermittent vs. Continuous HAART to Treat Chronic HIV InfectionCompletedNCT00025909Phase 3
• G-CSF to Treat Crohn's DiseaseCompletedNCT00025805Phase 1
• HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, PeruCompletedNCT00023582
• Antibody Production in Immune DisordersTerminatedNCT00023504Phase 4
• Steroid Withdrawal in Pediatric Kidney Transplant RecipientsTerminatedNCT00023244Phase 2
• Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
• Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and FibrosisWithdrawnNCT00023218Not applicable
• Treatment of Chronic Granulomatous Disease With Allogeneic Stem Cell Transplantation Versus Standard of CareCompletedNCT00023192Phase 3
• Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV InfectionCompletedNCT00023153Phase 3
• HIV Prevention Preparedness Study in Russia, China, and IndiaCompletedNCT00021775
• Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIVWithdrawnNCT00021762Phase 2
• Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV TransmissionCompletedNCT00021671Phase 3
• Effects of Ribavirin on Zidovudine or StavudineCompletedNCT00021632
• A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex InfectionsCompletedNCT00021567Phase 2
• Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV TreatmentWithdrawnNCT00021489Phase 2
• Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsCompletedNCT00021463Phase 2
• Anti-Interleukin-5 Antibody to Treat Hypereosinophilic SyndromeCompletedNCT00017862Phase 2
• Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant WomenCompletedNCT00017797
• Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV DrugsCompletedNCT00017771
• The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering DrugsCompletedNCT00017758Phase 1
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During PregnancyCompletedNCT00017719Phase 3
• Recombinant Human IL-4 Receptor Used in Treatment of AsthmaCompletedNCT00017693Phase 2
• Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIVCompletedNCT00016783
• Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected WomenCompletedNCT00016601Not applicable
• Effects of BufferGel and PRO 2000/5 Gel in MenCompletedNCT00016536Phase 1
• Effect of Interleukin-2 on HIV Treatment InterruptionCompletedNCT00015704Not applicable
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat AbnormalitiesCompletedNCT00015691Not applicable
• Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal InfectionsCompletedNCT00015665Phase 3
• Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV CoinfectionCompletedNCT00015652Not applicable
• Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal SymptomsCompletedNCT00015431
• Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination RegimenCompletedNCT00014937Not applicable
• A Study of Immune System Activity in Healthy AdultsCompletedNCT00014053
• Zidovudine and Lamivudine Given Once Versus Twice DailyCompletedNCT00014014Phase 1

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas